# EFFECTS OF EXTRACORPOREAL CYTOKINE ELIMINATION ON HEMODYNAMIA AND MORTALITY IN CRITICAL PATIENTS

> **NCT05984407** · — · UNKNOWN · sponsor: **Hakan Küçükkepeci** · enrollment: 30 (estimated)

## Conditions studied

- Cytokine Hemadsorption Therapy in Critically Ill Patients Who Have no Microbiological Findings and Develop Vasoplegic Shock

## Interventions

- **PROCEDURE:** cytokine hemadsorption therapy

## Key facts

- **NCT ID:** NCT05984407
- **Lead sponsor:** Hakan Küçükkepeci
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-08-01
- **Primary completion:** 2023-11-01
- **Final completion:** 2024-02-01
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2023-08-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05984407

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05984407, "EFFECTS OF EXTRACORPOREAL CYTOKINE ELIMINATION ON HEMODYNAMIA AND MORTALITY IN CRITICAL PATIENTS". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT05984407. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*